AIA
RLAY icon

AssuredPartners Investment Advisors’s Relay Therapeutics RLAY Stock Holding History

AssuredPartners Investment Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$150K Sell
12,062
-4,061
-25% -$36.3K 0.02% 394
2025
Q4 		$136K Buy
+16,123
New +$115K 0.02% 335
2025
Q2 		– Sell
-11,229
Closed -$29.4K – 310
2025
Q1 		$29.4K Buy
+11,229
New +$44K 0.01% 324

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

AssuredPartners Investment Advisors's RLAY Position: Q1 2026 in Review

AssuredPartners Investment Advisors reduced its Relay Therapeutics (RLAY) stake by 25% in Q1 2026, selling an estimated $36.3K and leaving 12,062 shares worth $150K. The position accounts for 0.02% of the portfolio, ranked #394.

AssuredPartners Investment Advisors first reported a position in RLAY in Q1 2025 and has held it in 3 quarters since. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • AssuredPartners Investment Advisors held 12,062 shares of Relay Therapeutics worth $150K as of Q1 2026.
  • AssuredPartners Investment Advisors sold 4,061 Relay Therapeutics shares in Q1 2026, an estimated $36.3K.
  • Relay Therapeutics made up 0.02% of AssuredPartners Investment Advisors's portfolio in Q1 2026, its #394 holding.
  • AssuredPartners Investment Advisors first reported a position in Relay Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on AssuredPartners Investment Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.